C. Günther

Comparison of In Vitro and In Vivo Percutaneous Absorption Across Human Skin Using BAY1003803 Formulated as Ointment and Cream

R. Nave, A. Jambrecina, F. Toner, 2019, Clinical pharmacology in drug development.

Percutaneous Absorption of Methylprednisolone Aceponate following Topical Application of Advantan® Lotion on Intact, Inflamed and Stripped Skin of Male Volunteers

U. Täuber, T. Staks, A. Kecskés, 1998, Skin Pharmacology and Physiology.

Development of Matrix Patches for Transdermal Delivery of a Highly Lipophilic Antiestrogen

R. Müller, A. Funke, R. Lipp, 2003, Drug development and industrial pharmacy.

In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS.

R. Müller, A. Funke, R. Lipp, 2002, Journal of controlled release : official journal of the Controlled Release Society.

DSC measurements on full thickness mice skin

A. Funke, C. Günther, R. Schiller, 2004 .

Transdermal Delivery of Highly Lipophilic Drugs: In Vitro Fluxes of Antiestrogens, Permeation Enhancers, and Solvents from Liquid Formulations

Rainer H. Müller, Ralph Lipp, R. Müller, 2002, Pharmaceutical Research.

Transfer of metaclazepam and its metabolites into breast milk.

G. Achtert, H. Hausleiter, C. Günther, 1989, Arzneimittel-Forschung.

Absorption of the stable prostacyclin analogue iloprost through the ulcer base in chronic venous insufficiency

J. Meyer, C. Günther, H. Werner-Schlenzka, 1993, The British journal of dermatology.

Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours.

Jürgen Hennig, Eric Masson, Yu-Yun Ho, 2005, European journal of cancer.

Prodrugs of Gestodene for Matrix-Type Transdermal Drug Delivery Systems

U. Täuber, R. Lipp, H. Laurent, 1998, Pharmaceutical Research.